160 related articles for article (PubMed ID: 2216188)
21. Radioimmunoguided surgery in primary colon cancer.
Nieroda CA; Mojzisik C; Sardi A; Ferrara PJ; Hinkle G; Thurston MO; Martin EW
Cancer Detect Prev; 1990; 14(6):651-6. PubMed ID: 2257564
[TBL] [Abstract][Full Text] [Related]
22. Preoperative and intraoperative radioimmunodetection of cancer pretargeted by biotinylated monoclonal antibodies.
Di Carlo V; De Nardi P; Stella M; Magnani P; Fazio F
Semin Surg Oncol; 1998 Dec; 15(4):235-8. PubMed ID: 9829379
[TBL] [Abstract][Full Text] [Related]
23. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
[TBL] [Abstract][Full Text] [Related]
24. Surgery for colorectal cancer guided by radiodetecting probe. Clinical evaluation using monoclonal antibody B72.3.
Stella M; De Nardi P; Paganelli G; Sassi I; Zito M; Magnani P; Baratti D; Mangili F; Spagnolo W; Siccardi AG
Eur J Surg; 1991 Aug; 157(8):485-8. PubMed ID: 1681938
[TBL] [Abstract][Full Text] [Related]
25. Role of B72.3 iodine 125-labeled monoclonal antibody in colorectal cancer detection by radioimmunoguided surgery.
Di Carlo V; Badellino F; Stella M; De Nardi P; Fazio F; Percivale P; Bertoglio S; Schenone F; Benevento A; Carcano G
Surgery; 1994 Feb; 115(2):190-8. PubMed ID: 8310407
[TBL] [Abstract][Full Text] [Related]
26. Role of tumor-associated antigen expression in radioimmunoguided surgery for colorectal and breast cancer.
Bertoglio S; Percivale P; Schenone F; Peressini A; Murolo C; Badellino F
Semin Surg Oncol; 1998 Dec; 15(4):249-53. PubMed ID: 9829382
[TBL] [Abstract][Full Text] [Related]
27. Avidin-biotin system in radioimmunoguided surgery for colorectal cancer. Advantages and limits.
Stella M; De Nardi P; Paganelli G; Magnani P; Mangili F; Sassi I; Baratti D; Gini P; Zito F; Cristallo M
Dis Colon Rectum; 1994 Apr; 37(4):335-43. PubMed ID: 8168412
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and intraoperative immunoscintigraphy in ovarian cancer.
Gitsch E; Pateisky N; Schatten C
Eur J Obstet Gynecol Reprod Biol; 1989 Jul; 32(1):33-7. PubMed ID: 2767320
[TBL] [Abstract][Full Text] [Related]
29. Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second-generation monoclonal antibody.
Arnold MW; Schneebaum S; Berens A; Petty L; Mojzisik C; Hinkle G; Martin EW
Ann Surg; 1992 Dec; 216(6):627-32. PubMed ID: 1466615
[TBL] [Abstract][Full Text] [Related]
30. [Iodine-125 labeled monoclonal antibody 3H11: in radioimmunoguided surgery for primary gastric cancer].
Wang C; Wang Y; Su X; Lin B; Xu X; Zhang M; Li J; Xu G
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):507-9. PubMed ID: 11832094
[TBL] [Abstract][Full Text] [Related]
31. Localization of biotinylated monoclonal antibodies (B72.3 and F023C5) in patients with colorectal cancer.
Mangili F; Stella M; Sassi I; Ferrara F; Paganelli G; De Nardi P; Cantaboni A
Eur J Histochem; 1993; 37(1):53-7. PubMed ID: 7682868
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of therapeutic response using iodine-131-B72.3 monoclonal antibody in patients with ovarian carcinoma.
Camera L; Del Vecchio S; Petrillo A; Esposito G; Frasci G; Iaffaioli RV; Bianco AR; Salvatore M
Eur J Nucl Med; 1991; 18(4):269-73. PubMed ID: 2070805
[TBL] [Abstract][Full Text] [Related]
33. Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer.
Surwit EA; Childers JM; Krag DN; Katterhagen JG; Gallion HH; Waggoner S; Mann WJ
Gynecol Oncol; 1993 Mar; 48(3):285-92. PubMed ID: 8462896
[TBL] [Abstract][Full Text] [Related]
34. Gamma probe location of 111indium-labeled B72.3: an extension of immunoscintigraphy.
Krag DN; Haseman MK; Ford P; Smith L; Taylor MH; Schneider P; Goodnight JE
J Surg Oncol; 1992 Dec; 51(4):226-30. PubMed ID: 1434652
[TBL] [Abstract][Full Text] [Related]
35. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J
Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
[TBL] [Abstract][Full Text] [Related]
36. Improved tumor radioimmunodetection using a single-chain Fv and gamma-interferon: potential clinical applications for radioimmunoguided surgery and gamma scanning.
Nieroda CA; Milenic DE; Carrasquillo JA; Scholm J; Greiner JW
Cancer Res; 1995 Jul; 55(13):2858-65. PubMed ID: 7796413
[TBL] [Abstract][Full Text] [Related]
37. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma].
Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P
Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855
[TBL] [Abstract][Full Text] [Related]
38. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
39. Peroperative radioimmunodetection of ovarian carcinoma using a hand-held gamma detection probe.
Ind TE; Granowska M; Britton KE; Morris G; Lowe DG; Hudson CN; Shepherd JH
Br J Cancer; 1994 Dec; 70(6):1263-6. PubMed ID: 7981086
[TBL] [Abstract][Full Text] [Related]
40. Radioimmunoguided surgery (RIGS), PET/CT image-guided surgery, and fluorescence image-guided surgery: past, present, and future.
Sun D; Bloomston M; Hinkle G; Al-Saif OH; Hall NC; Povoski SP; Arnold MW; Martin EW
J Surg Oncol; 2007 Sep; 96(4):297-308. PubMed ID: 17726663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
